GARS1 and neuropathy: This determination will require additional comparisons, including comparisons to Gars mutations at different time points and to other neuropathy models; however, these results provide an excellent starting point for such studies, and an interesting point of comparison for metabolomics studies on other related diseases as such data becomes available.